Validation and clinical evaluation of a comprehensive circulating tumor DNA assay for genomic profiling in solid tumors
Lisa Schöpfer, Lucia Zisser, Felicitas Oberndorfer, Ana-Iris Schiefer, Eva Maria Compérat, Leonhard Müllauer, André Oszwald · 2025
Read Validation and clinical evaluation of a comprehensive circulating tumor DNA assay for genomic profiling in solid tumors by Lisa Schöpfer, Lucia Zisser, Felicitas Oberndorfer, Ana-Iris Schiefer, Eva Maria Compérat, Leonhard Müllauer, André Oszwald (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12798125.txt.
Description
Lisa Schöpfer and a team of co-authors report on a blood test that profiles tumor DNA, in two thousand twenty-five. A Vienna hospital has used the test since two thousand twenty-three, first for cases where a tissue sample was not possible. The test reads DNA that tumors shed into the blood.
Checks showed the test caught most small gene changes at very low levels. Gene changes that could guide drug choice turned up in more than a quarter of samples. Results led to a documented change in care for about one in nine patients reviewed. The authors say poor paperwork and weak links to care plans limit the test's impact.
Catalog record
| CREATOR | Lisa Schöpfer, Lucia Zisser, Felicitas Oberndorfer, Ana-Iris Schiefer, Eva Maria Compérat, Leonhard Müllauer, André Oszwald |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 67 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |